About: Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://dx.doi.org/10.4172/1948-5956.S2-005
Description	Endocrine therapy is an essential modality in patients with hormone receptor positive breast cancer. Even with high therapeutic efficacy of first-line hormonal treatment, most patients with metastatic breast cancer will develop resistance. Endocrine therapy is an essential modality in patients with hormone receptor positive breast cancer. Even with high therapeutic efficacy of first-line hormonal treatment, most patients with metastatic breast cancer will develop resistance. (en)
Title	Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors (en)
skos:prefLabel	Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors Breast cancer patients resistant to endocrine therapy show decreased number of cytotoxic supressor cells and enhanced production of neoangiogenetic and immunosupressive factors (en)
skos:notation	RIV/00064165:_____/11:9726!RIV12-MZ0-00064165
http://linked.open...avai/riv/aktivita	I P
http://linked.open...avai/riv/aktivity	I, P(NT11168)
http://linked.open...iv/cisloPeriodika	S2
http://linked.open...vai/riv/dodaniDat	2012
http://linked.open...aciTvurceVysledku	Závadová, Eva Konopásek, Bohuslav Petruželka, Luboš
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Všeobecná fakultní nemocnice v Praze / (nerozlišená součást)
http://linked.open...dnocenehoVysledku	188725
http://linked.open...ai/riv/idVysledku	RIV/00064165:_____/11:9726
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	VEGF; TGF beta cellular immunity; breast cancer; hormonal therapy (en)
http://linked.open.../riv/klicoveSlovo	breast cancer TGF beta cellular immunity VEGF hormonal therapy
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[8B4454B0E97C]
http://linked.open...i/riv/nazevZdroje	Journal of Cancer Science and Therapy
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	3 (xsd:int)
http://linked.open...cetTvurcuVysledku	5 (xsd:int)
http://linked.open...vavai/riv/projekt	Transforming growth factor – beta 1(TGF-beta 1) and a Vascular endotelial growth factor (VEGF) in the plasma of breast cancer patients resistent to antiestrogen therapy.
http://linked.open...UplatneniVysledku	2011
http://linked.open...v/svazekPeriodika	2011
http://linked.open...iv/tvurceVysledku	Fučíková, Terezie Konopásek, Bohuslav Petruželka, Luboš Vočka, Michal Závadová, Eva
issn	1948-5956
number of pages	4 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software